trimetazidine has been researched along with Recrudescence in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Challeton, JP; Correges, A; Danchin, N; Ferrari, R; Ford, I; Fox, K; Tendera, M; Widimský, P | 1 |
| Challeton, JP; Danchin, N; Ferrari, R; Ford, I; Fox, K; Marzilli, M; Tendera, M; Widimský, P | 1 |
| Asymbekova, EU; Sherstyannikova, OM; Tugeeva, EF | 1 |
| Szwed, H | 1 |
| Elikowski, W; Grzelak-Szafranska, H; Orszulak, W; Ruzyllo, W; Sadowski, Z; Szwed, H; Szymczak, K; Winter, M | 1 |
| Antonov, AIa; Bryl', ZhV; Irkin, OI; Parkhomenko, AE; Shkliar, LV | 1 |
1 review(s) available for trimetazidine and Recrudescence
| Article | Year |
|---|---|
Clinical benefits of trimetazidine in patients with recurrent angina.
Topics: Angina Pectoris; Humans; Myocardial Revascularization; Randomized Controlled Trials as Topic; Recurrence; Trimetazidine; Vasodilator Agents | 2004 |
4 trial(s) available for trimetazidine and Recrudescence
| Article | Year |
|---|---|
Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial.
Topics: Administration, Oral; Africa, Northern; Aged; Angina, Stable; Angina, Unstable; Asia; Case-Control Studies; Coronary Angiography; Death; Europe; Female; Hospitalization; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Placebos; Recurrence; Safety; South America; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2020 |
A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristi
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Coronary Artery Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Placebos; Postoperative Complications; Recurrence; Trimetazidine; Vasodilator Agents; Young Adult | 2019 |
Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the TRIMPOL II study.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Humans; Male; Metoprolol; Middle Aged; Recurrence; Trimetazidine; Vasodilator Agents | 2004 |
[The use of the antioxidant trimetazidine (Preductal) in the combined therapy of acute myocardial infarct].
Topics: Adult; Aged; Antioxidants; Drug Therapy, Combination; Heart Function Tests; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Tablets; Time Factors; Trimetazidine | 1996 |
1 other study(ies) available for trimetazidine and Recrudescence
| Article | Year |
|---|---|
[Clinical Case Demonstrating Use of Trimetazidine In the Treatment of Stable Angina].
Topics: Angina, Stable; Humans; Male; Middle Aged; Quality of Life; Recurrence; Trimetazidine; Vasodilator Agents | 2016 |